CXCR3 and cancer: Regarding mouse malignant gliomas, when GL261 cancer cells were transfected with CXCL10 and subcutaneously transplanted into mice, tumor progression was significantly delayed, suggesting that the CXCL10/CXCR3 pathway can effectively inhibit tumor progression.